Covis Drug Patent Portfolio
Covis owns 9 orange book drugs protected by 51 US patents with Rilutek having the least patent protection, holding only 1 patent. And Tudorza Pressair with maximum patent protection, holding 13 patents. Given below is the list of Covis's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10471075 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US11154562 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US11304962 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US9844558 | Methods of reducing risk of preterm birth | 02 May, 2036 | Active |
| US9789257 | Needle assisted injection device having reduced trigger force | 11 Feb, 2034 | Active |
| US11446440 | Needle assisted injection device having reduced trigger force | 21 Aug, 2031 | Active |
| US10085974 | Dosage and formulation | 13 Mar, 2029 | Active |
| US11000517 | Dosage and formulation | 13 Mar, 2029 | Active |
| US8371292 | Use of ciclesonide for the treatment of respiratory diseases | 01 Feb, 2028 | Active |
| US8051851 | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler | 22 Apr, 2027 | Active |
| US8021335 | Prefilled syringe jet injector | 04 Oct, 2026 | Active |
| US11446441 | Prefilled syringe injector | 24 Jan, 2026 | Expired |
| US8562564 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9180259 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9533102 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| US9629959 | Prefilled syringe jet injector | 24 Jan, 2026 | Expired |
| USRE46417 | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands | 10 Feb, 2025 | Expired |
| US6681768 | Powder formulation disintegrating system and method for dry powder inhalers | 07 Aug, 2022 | Expired |
| US6767901 | Ciclesonide contained pharmaceutical composition for application to mucosa | 21 Oct, 2020 | Expired |
| US8383611 | Ciclesonide containing aqueous pharmaceutical composition | 20 Oct, 2020 | Expired |
| US6750226 | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands | 05 Sep, 2020 | Expired |
| US7078412 | Quinuclidine derivatives and medicinal compositions containing the same | 16 Jul, 2020 | Expired |
| US10034867 | Quinuclidine derivatives and medicinal compositions containing the same | 07 Jul, 2020 | Expired |
| US10588895 | Quinuclidine derivatives and medicinal compositions containing the same | 07 Jul, 2020 | Expired |
| US7750023 | Quinuclidine derivatives and medicinal compositions containing the same | 07 Jul, 2020 | Expired |
| US8129405 | Quinuclidine derivatives and medicinal compositions containing the same | 07 Jul, 2020 | Expired |
| US9056100 | Quinuclidine derivatives and medicinal compositions containing the same | 07 Jul, 2020 | Expired |
| US9333195 | Quinuclidine derivatives and medicinal compositions containing the same | 07 Jul, 2020 | Expired |
| US6599498 | Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives | 08 Mar, 2020 | Expired |
| US7553479 | Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof | 08 Mar, 2020 | Expired |
| US7871597 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| US8501158 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| US8591864 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| US8926947 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents | 08 Mar, 2020 | Expired |
| USRE44846 | Needle assisted jet injector | 10 Aug, 2019 | Expired |
| US6939559 | Pharmaceutical composition for application to mucosa | 21 Apr, 2019 | Expired |
| US7235247 | Pharmaceutical composition for application to mucosa | 21 Apr, 2019 | Expired |
| US6120752 | Medicinal aerosol products containing formulations of ciclesonide and related steroids | 13 May, 2018 | Expired |
| US6264923 | Medicinal aerosol formulation of ciclesonide and related compounds | 13 May, 2018 | Expired |
| US6080778 | Methods for decreasing beta amyloid protein | 23 Mar, 2018 | Expired |
| US5916595 | HMG co-reductase inhibitor | 12 Dec, 2017 | Expired |
| US6485748 | Once daily pharmaceutical tablet having a unitary core | 12 Dec, 2017 | Expired |
| US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions | 24 Oct, 2017 | Expired |
| US6006745 | Device for delivering an aerosol | 28 Dec, 2016 | Expired |
| US5840279 | Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments | 21 Jun, 2016 | Expired |
| US6071498 | Inhaler for powdered medicaments | 21 Jun, 2016 | Expired |
| US5775321 | Seal configuration for aerosol canister | 07 Jul, 2015 | Expired |
| US5683677 | Medicinal aerosol formulations | 04 Nov, 2014 | Expired |
| US5605674 | Medicinal aerosol formulations | 25 Feb, 2014 | Expired |
| US5527814 | Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis | 18 Jun, 2013 | Expired |
| US6036942 | Seal configuration for aerosol canister | 30 Apr, 2013 | Expired |
Latest Legal Activities on Covis's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Covis.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 28 Apr, 2025 | US11154562 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 17 Apr, 2025 | US8562564 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 17 Apr, 2025 | US9789257 |
| Expire Patent | 31 Mar, 2025 | US8383611 |
| Correspondence Address Change | 12 Dec, 2024 | US11446440 |
| Correspondence Address Change | 12 Dec, 2024 | US9789257 |
| Correspondence Address Change | 12 Dec, 2024 | US9533102 |
| Correspondence Address Change | 12 Dec, 2024 | US9180259 |
| Correspondence Address Change | 12 Dec, 2024 | US11446441 |
| Correspondence Address Change | 12 Dec, 2024 | US9629959 |
| Correspondence Address Change | 12 Dec, 2024 | US8562564 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Nov, 2024 | US11000517 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Nov, 2024 | US11000517 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Oct, 2024 | US9629959 |
| Maintenance Fee Reminder Mailed | 14 Oct, 2024 | US8383611 |
Covis's Drug Patent Litigations
Covis's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Nov 23, 2009, against patent number US8383611. The petitioner , challenged the validity of this patent, with Atsuhiro Nagano et al as the respondent. Click below to track the latest information on how companies are challenging Covis's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8383611 | November, 2009 |
Decision
(22 Feb, 2011)
| Atsuhiro Nagano et al | |
Covis Drug Patents' Oppositions Filed in EPO
Covis drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Sep 25, 2014, by Generics [Uk] Ltd (Trading As Mylan). This opposition was filed on patent number EP04766791A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
| | |||
| EP19150366A | Sep, 2022 | Bandpay & Greuter | Granted and Under Opposition |
| EP06719329A | Oct, 2019 | Bandpay & Greuter | Patent maintained as amended |
| EP09719213A | May, 2016 | Generics (U.K.) Limited | Granted and Under Opposition |
| EP09719213A | May, 2016 | Hexal AG | Granted and Under Opposition |
| EP04766791A | Sep, 2014 | Generics [UK] Ltd (trading as Mylan) | Patent maintained as amended |
Covis's Family Patents
Covis Drug List
Given below is the complete list of Covis's drugs and the patents protecting them.
1. Altoprev
Altoprev is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6080778 | Methods for decreasing beta amyloid protein |
23 Mar, 2018
(8 years ago)
| Expired |
| US5916595 | HMG co-reductase inhibitor |
12 Dec, 2017
(8 years ago)
| Expired |
| US6485748 | Once daily pharmaceutical tablet having a unitary core |
12 Dec, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Altoprev's drug page
2. Alvesco
Alvesco is protected by 9 patents, out of which 8 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8371292 | Use of ciclesonide for the treatment of respiratory diseases |
01 Feb, 2028
(1 year, 10 months from now)
| Active |
| US6120752 | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
13 May, 2018
(7 years ago)
| Expired |
| US6264923 | Medicinal aerosol formulation of ciclesonide and related compounds |
13 May, 2018
(7 years ago)
| Expired |
| US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
24 Oct, 2017
(8 years ago)
| Expired |
| US6006745 | Device for delivering an aerosol |
28 Dec, 2016
(9 years ago)
| Expired |
| US5775321 | Seal configuration for aerosol canister |
07 Jul, 2015
(10 years ago)
| Expired |
| US5683677 | Medicinal aerosol formulations |
04 Nov, 2014
(11 years ago)
| Expired |
| US5605674 | Medicinal aerosol formulations |
25 Feb, 2014
(12 years ago)
| Expired |
| US6036942 | Seal configuration for aerosol canister |
30 Apr, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvesco's drug page
3. Duaklir Pressair
Duaklir Pressair is protected by 12 patents, out of which 9 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10085974 | Dosage and formulation |
13 Mar, 2029
(2 years from now)
| Active |
| US11000517 | Dosage and formulation |
13 Mar, 2029
(2 years from now)
| Active |
| US8051851 | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler |
22 Apr, 2027
(1 year, 25 days from now)
| Active |
| USRE46417 | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands |
10 Feb, 2025
(1 year, 1 month ago)
| Expired |
| US6681768 | Powder formulation disintegrating system and method for dry powder inhalers |
07 Aug, 2022
(3 years ago)
| Expired |
| US10034867 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US10588895 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US7078412 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US7750023 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US8129405 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US9056100 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US9333195 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Duaklir Pressair's drug page
4. Feraheme
Feraheme is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6599498 | Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives |
08 Mar, 2020
(6 years ago)
| Expired |
| US7553479 | Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
08 Mar, 2020
(6 years ago)
| Expired |
| US7871597 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
| US8501158 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
| US8591864 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
| US8926947 | Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
08 Mar, 2020
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Feraheme's drug page
5. Makena (autoinjector)
Makena (autoinjector) is protected by 13 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10471075 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US11154562 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US11304962 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US9844558 | Methods of reducing risk of preterm birth |
02 May, 2036
(10 years from now)
| Active |
| US9789257 | Needle assisted injection device having reduced trigger force |
11 Feb, 2034
(7 years from now)
| Active |
| US11446440 | Needle assisted injection device having reduced trigger force |
21 Aug, 2031
(5 years from now)
| Active |
| US8021335 | Prefilled syringe jet injector |
04 Oct, 2026
(6 months from now)
| Active |
| US11446441 | Prefilled syringe injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US8562564 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US9180259 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US9533102 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| US9629959 | Prefilled syringe jet injector |
24 Jan, 2026
(2 months ago)
| Expired |
| USRE44846 | Needle assisted jet injector |
10 Aug, 2019
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Makena (autoinjector)'s drug page
Explore Our Curated Drug Screens
6. Omnaris
Omnaris is protected by 6 patents, out of which 5 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8371292 | Use of ciclesonide for the treatment of respiratory diseases |
01 Feb, 2028
(1 year, 10 months from now)
| Active |
| US6767901 | Ciclesonide contained pharmaceutical composition for application to mucosa |
21 Oct, 2020
(5 years ago)
| Expired |
| US8383611 | Ciclesonide containing aqueous pharmaceutical composition |
20 Oct, 2020
(5 years ago)
| Expired |
| US6939559 | Pharmaceutical composition for application to mucosa |
21 Apr, 2019
(6 years ago)
| Expired |
| US7235247 | Pharmaceutical composition for application to mucosa |
21 Apr, 2019
(6 years ago)
| Expired |
| US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
24 Oct, 2017
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Omnaris's drug page
7. Rilutek
Rilutek is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5527814 | Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis |
18 Jun, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rilutek's drug page
8. Tudorza Pressair
Tudorza Pressair is protected by 13 patents, out of which 10 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10085974 | Dosage and formulation |
13 Mar, 2029
(2 years from now)
| Active |
| US11000517 | Dosage and formulation |
13 Mar, 2029
(2 years from now)
| Active |
| US8051851 | Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler |
22 Apr, 2027
(1 year, 25 days from now)
| Active |
| USRE46417 | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands |
10 Feb, 2025
(1 year, 1 month ago)
| Expired |
| US6681768 | Powder formulation disintegrating system and method for dry powder inhalers |
07 Aug, 2022
(3 years ago)
| Expired |
| US6750226 | Quinuclidine derivatives and their use as muscarinic M3 receptor ligands |
05 Sep, 2020
(5 years ago)
| Expired |
| US7078412 | Quinuclidine derivatives and medicinal compositions containing the same |
16 Jul, 2020
(5 years ago)
| Expired |
| US10034867 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US10588895 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US9056100 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US9333195 | Quinuclidine derivatives and medicinal compositions containing the same |
07 Jul, 2020
(5 years ago)
| Expired |
| US5840279 | Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments |
21 Jun, 2016
(9 years ago)
| Expired |
| US6071498 | Inhaler for powdered medicaments |
21 Jun, 2016
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tudorza Pressair's drug page
9. Zetonna
Zetonna is protected by 9 patents, out of which 8 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8371292 | Use of ciclesonide for the treatment of respiratory diseases |
01 Feb, 2028
(1 year, 10 months from now)
| Active |
| US6120752 | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
13 May, 2018
(7 years ago)
| Expired |
| US6264923 | Medicinal aerosol formulation of ciclesonide and related compounds |
13 May, 2018
(7 years ago)
| Expired |
| US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
24 Oct, 2017
(8 years ago)
| Expired |
| US6006745 | Device for delivering an aerosol |
28 Dec, 2016
(9 years ago)
| Expired |
| US5775321 | Seal configuration for aerosol canister |
07 Jul, 2015
(10 years ago)
| Expired |
| US5683677 | Medicinal aerosol formulations |
04 Nov, 2014
(11 years ago)
| Expired |
| US5605674 | Medicinal aerosol formulations |
25 Feb, 2014
(12 years ago)
| Expired |
| US6036942 | Seal configuration for aerosol canister |
30 Apr, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zetonna's drug page